Leksell Vantage Stereotactic System 1128643
Listed
Valid until
Not applicable
FDA recalls
2 ongoingDocuments
None
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | GUDID listing | Number07340201503577 | Date8 Sep 2026 | StatusListed |
Recalls
-
- Ongoing Z-2006-2026
Locking mechanisms may not properly secure to the Arc system, resulting in shifting of coordinates during procedures.
-
- Ongoing Z-0433-2026
Due to increased risk that paint flakes from the engravings may separate from the device and there is the possibility that the flake may inadvertently enter the wound
-
- Terminated Z-1826-2020
A faulty locking piece of the Instrument Carrier that does not fulfil the requirement of locking force to the Arc has been found during an internal check of a Leksell Vantage Stereotactic Arc System.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — GUDID listing Listed
Specification
- Trade Name
- Leksell Vantage Stereotactic System
- Generic Name
- Neurological stereotactic surgery system
- Model / Reference
- 1128643
- Primary DI / UDI-DI
- 07340201503577
- 510(k) Number
- FDA Product Code
- HAW
- GMDN Term
- Neurological stereotactic surgery system
- Device Class
- Class II
- Regulation Number
- 882.4560
- GUDID distribution status
- In Commercial Distribution
- Sterilization Method
- Moist Heat or Steam Sterilization
- MRI Safety
- MR Conditional
Other devices from Elekta Solutions AB
Properties
Other properties (11)
- Sterile: No
- Single Use: No
- Implantable: No
- Contains Latex: No
- Over-the-Counter: No
- Convenience Kit: No
- Combination Product: No
- HCT/P: No
- Premarket Exempt: No
- Lot / Batch Number: No
- Expiration Date: No